Trial · NCT01204918
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Riluzole Addition to SSRI Antidepressant | 25 | |
| Overall Study | STARTED | Riluzole/Placebo Addition to SSRI Antidepressant | 39 | |
| Overall Study | STARTED | Placebo Addition to Standard SSRI Antidepressant | 40 | |
| Overall Study | Stage 1 Begin | Riluzole Addition to SSRI Antidepressant | 25 | |
| Overall Study | Stage 1 Begin | Riluzole/Placebo Addition to SSRI Antidepressant | 39 | |
| Overall Study | Stage 1 Begin | Placebo Addition to Standard SSRI Antidepressant | 40 | |
| Overall Study | Stage 1 End | Riluzole Addition to SSRI Antidepressant | 22 | |
| Overall Study | Stage 1 End | Riluzole/Placebo Addition to SSRI Antidepressant | 35 | |
| Overall Study | Stage 1 End | Placebo Addition to Standard SSRI Antidepressant | 36 | |
| Overall Study | Stage 2 Begin | Riluzole Addition to SSRI Antidepressant | 22 | |
| Overall Study | Stage 2 Begin | Riluzole/Placebo Addition to SSRI Antidepressant | 35 | |
| Overall Study | Stage 2 Begin | Placebo Addition to Standard SSRI Antidepressant | 36 | |
| Overall Study | Stage 2 End | Riluzole Addition to SSRI Antidepressant | 21 | |
| Overall Study | Stage 2 End | Riluzole/Placebo Addition to SSRI Antidepressant | 29 | |
| Overall Study | Stage 2 End | Placebo Addition to Standard SSRI Antidepressant | 35 | |
| Overall Study | COMPLETED | Riluzole Addition to SSRI Antidepressant | 21 | |
| Overall Study | COMPLETED | Riluzole/Placebo Addition to SSRI Antidepressant | 29 | |
| Overall Study | COMPLETED | Placebo Addition to Standard SSRI Antidepressant | 35 | |
| Overall Study | NOT COMPLETED | Riluzole Addition to SSRI Antidepressant | 4 | |
| Overall Study | NOT COMPLETED | Riluzole/Placebo Addition to SSRI Antidepressant | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01204918/flow